ID   LTC4S_HUMAN             Reviewed;         150 AA.
AC   Q16873; Q8N6P0; Q9UC73; Q9UD18;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   15-MAR-2017, entry version 156.
DE   RecName: Full=Leukotriene C4 synthase;
DE            Short=LTC4 synthase;
DE            EC=4.4.1.20;
DE   AltName: Full=Leukotriene-C(4) synthase;
GN   Name=LTC4S;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 1-22 AND 35-48.
RC   TISSUE=Bone marrow;
RX   PubMed=8052639; DOI=10.1073/pnas.91.16.7663;
RA   Lam B.K., Penrose J.F., Freeman G.J., Austen K.F.;
RT   "Expression cloning of a cDNA for human leukotriene C4 synthase, an
RT   integral membrane protein conjugating reduced glutathione to
RT   leukotriene A4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:7663-7667(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7937884; DOI=10.1073/pnas.91.21.9745;
RA   Welsch D.J., Creely D.P., Hauser S.D., Mathis K.J., Krivi G.G.,
RA   Isakson P.C.;
RT   "Molecular cloning and expression of human leukotriene-C4 synthase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:9745-9749(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8626689; DOI=10.1074/jbc.271.19.11356;
RA   Penrose J.F., Spector J., Baldasaro M., Xu K., Boyce J., Arm J.P.,
RA   Austen K.F., Lam B.K.;
RT   "Molecular cloning of the gene for human leukotriene C4 synthase.
RT   Organization, nucleotide sequence, and chromosomal localization to
RT   5q35.";
RL   J. Biol. Chem. 271:11356-11361(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8898379;
RA   Bigby T.D., Hodulik C.R., Arden K.C., Fu L.;
RT   "Molecular cloning of the human leukotriene C4 synthase gene and
RT   assignment to chromosome 5q35.";
RL   Mol. Med. 2:637-646(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-142.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-35.
RX   PubMed=8446623; DOI=10.1073/pnas.90.5.2015;
RA   Nicholson D.W., Ali A., Vaillancourt J.P., Calaycay J.R.,
RA   Mumford R.A., Zamboni R.J., Ford-Hutchinson A.W.;
RT   "Purification to homogeneity and the N-terminal sequence of human
RT   leukotriene C4 synthase: a homodimeric glutathione S-transferase
RT   composed of 18-kDa subunits.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:2015-2019(1993).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-19, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Lung;
RX   PubMed=7599836; DOI=10.1164/ajrccm.152.1.7599836;
RA   Penrose J.F., Spector J., Lam B.K., Friend D.S., Xu K., Jack R.M.,
RA   Austen K.F.;
RT   "Purification of human lung leukotriene C4 synthase and preparation of
RT   a polyclonal antibody.";
RL   Am. J. Respir. Crit. Care Med. 152:283-289(1995).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-17.
RC   TISSUE=Monocyte;
RX   PubMed=7766706; DOI=10.1016/0005-2760(95)00031-7;
RA   Goppelt-Struebe M.;
RT   "Two step purification of human and murine leukotriene C4 synthase.";
RL   Biochim. Biophys. Acta 1256:257-261(1995).
RN   [9]
RP   INVOLVEMENT IN LTC4 SYNTHASE DEFICIENCY.
RX   PubMed=9820300; DOI=10.1016/S0140-6736(98)01186-6;
RA   Mayatepek E., Flock B.;
RT   "Leukotriene C4-synthesis deficiency: a new inborn error of metabolism
RT   linked to a fatal developmental syndrome.";
RL   Lancet 352:1514-1517(1998).
RN   [10]
RP   INVOLVEMENT IN LTC4 SYNTHASE DEFICIENCY.
RX   PubMed=10896305; DOI=10.1023/A:1005664204956;
RA   Mayatepek E., Zelezny R., Lehmann W.D., Hammond J.W., Hoffmann G.F.;
RT   "Defects in the synthesis of cysteinyl leukotrienes: a new group of
RT   inborn errors of metabolism.";
RL   J. Inherit. Metab. Dis. 23:404-408(2000).
RN   [11]
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=12023288; DOI=10.1074/jbc.M203074200;
RA   Christmas P., Weber B.M., McKee M., Brown D., Soberman R.J.;
RT   "Membrane localization and topology of leukotriene C4 synthase.";
RL   J. Biol. Chem. 277:28902-28908(2002).
RN   [12]
RP   INTERACTION WITH ALOX5AP AND ALOX5, AND SUBCELLULAR LOCATION.
RX   PubMed=19233132; DOI=10.1016/j.bbrc.2009.02.074;
RA   Strid T., Svartz J., Franck N., Hallin E., Ingelsson B.,
RA   Soederstroem M., Hammarstroem S.;
RT   "Distinct parts of leukotriene C(4) synthase interact with 5-
RT   lipoxygenase and 5-lipoxygenase activating protein.";
RL   Biochem. Biophys. Res. Commun. 381:518-522(2009).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE,
RP   ACTIVE SITE, TOPOLOGY, AND SUBUNIT.
RX   PubMed=17632548; DOI=10.1038/nature05936;
RA   Ago H., Kanaoka Y., Irikura D., Lam B.K., Shimamura T., Austen K.F.,
RA   Miyano M.;
RT   "Crystal structure of a human membrane protein involved in cysteinyl
RT   leukotriene biosynthesis.";
RL   Nature 448:609-612(2007).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 2-150 IN COMPLEX WITH
RP   GLUTATHIONE, SUBUNIT, AND TOPOLOGY.
RX   PubMed=17632546; DOI=10.1038/nature06009;
RA   Martinez Molina D., Wetterholm A., Kohl A., McCarthy A.A.,
RA   Niegowski D., Ohlson E., Hammarberg T., Eshaghi S., Haeggstroem J.Z.,
RA   Nordlund P.;
RT   "Structural basis for synthesis of inflammatory mediators by human
RT   leukotriene C4 synthase.";
RL   Nature 448:613-616(2007).
CC   -!- FUNCTION: Catalyzes the conjugation of leukotriene A4 with reduced
CC       glutathione to form leukotriene C4.
CC   -!- CATALYTIC ACTIVITY: Leukotriene C(4) = leukotriene A(4) +
CC       glutathione.
CC   -!- SUBUNIT: Homotrimer. Interacts with ALOX5AP and ALOX5.
CC       {ECO:0000269|PubMed:17632546, ECO:0000269|PubMed:17632548,
CC       ECO:0000269|PubMed:19233132}.
CC   -!- SUBCELLULAR LOCATION: Nucleus outer membrane; Multi-pass membrane
CC       protein. Endoplasmic reticulum membrane; Multi-pass membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Detected in lung, platelets and the
CC       myelogenous leukemia cell line KG-1 (at protein level). LTC4S
CC       activity is present in eosinophils, basophils, mast cells, certain
CC       phagocytic mononuclear cells, endothelial cells, vascular smooth
CC       muscle cells and platelets. {ECO:0000269|PubMed:7599836}.
CC   -!- DISEASE: Note=LTC4 synthase deficiency is associated with a
CC       neurometabolic developmental disorder characterized by muscular
CC       hypotonia, psychomotor retardation, failure to thrive, and
CC       microcephaly.
CC   -!- SIMILARITY: Belongs to the MAPEG family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U09353; AAA20467.1; -; mRNA.
DR   EMBL; U11552; AAA50555.1; -; mRNA.
DR   EMBL; U50136; AAC50476.1; -; Genomic_DNA.
DR   EMBL; U62025; AAB06723.1; -; Genomic_DNA.
DR   EMBL; BC029498; AAH29498.1; -; mRNA.
DR   CCDS; CCDS34316.1; -.
DR   PIR; I38595; I38595.
DR   PIR; JC5398; JC5398.
DR   RefSeq; NP_665874.1; NM_145867.1.
DR   UniGene; Hs.706741; -.
DR   PDB; 2PNO; X-ray; 3.30 A; A/B/C/D/E/F/G/H/I/J/K/L=1-150.
DR   PDB; 2UUH; X-ray; 2.15 A; A=2-150.
DR   PDB; 2UUI; X-ray; 2.00 A; A=2-150.
DR   PDB; 3B29; X-ray; 3.20 A; A=1-150.
DR   PDB; 3HKK; X-ray; 2.90 A; A=2-150.
DR   PDB; 3LEO; X-ray; 2.10 A; A=2-150.
DR   PDB; 3PCV; X-ray; 1.90 A; A=1-150.
DR   PDB; 4J7T; X-ray; 3.20 A; A=2-150.
DR   PDB; 4J7Y; X-ray; 2.90 A; A=2-150.
DR   PDB; 4JC7; X-ray; 2.70 A; A=2-150.
DR   PDB; 4JCZ; X-ray; 2.75 A; A=2-150.
DR   PDB; 4JRZ; X-ray; 2.40 A; A=2-150.
DR   PDB; 4WAB; X-ray; 2.70 A; A=130-150.
DR   PDB; 5HV9; X-ray; 3.00 A; A=2-150.
DR   PDBsum; 2PNO; -.
DR   PDBsum; 2UUH; -.
DR   PDBsum; 2UUI; -.
DR   PDBsum; 3B29; -.
DR   PDBsum; 3HKK; -.
DR   PDBsum; 3LEO; -.
DR   PDBsum; 3PCV; -.
DR   PDBsum; 4J7T; -.
DR   PDBsum; 4J7Y; -.
DR   PDBsum; 4JC7; -.
DR   PDBsum; 4JCZ; -.
DR   PDBsum; 4JRZ; -.
DR   PDBsum; 4WAB; -.
DR   PDBsum; 5HV9; -.
DR   ProteinModelPortal; Q16873; -.
DR   SMR; Q16873; -.
DR   BioGrid; 110234; 4.
DR   DIP; DIP-48473N; -.
DR   IntAct; Q16873; 1.
DR   STRING; 9606.ENSP00000292596; -.
DR   BindingDB; Q16873; -.
DR   ChEMBL; CHEMBL1743183; -.
DR   DrugBank; DB00143; Glutathione.
DR   GuidetoPHARMACOLOGY; 1391; -.
DR   SwissLipids; SLP:000001452; -.
DR   iPTMnet; Q16873; -.
DR   PhosphoSitePlus; Q16873; -.
DR   DMDM; 2833283; -.
DR   PaxDb; Q16873; -.
DR   PeptideAtlas; Q16873; -.
DR   PRIDE; Q16873; -.
DR   DNASU; 4056; -.
DR   Ensembl; ENST00000292596; ENSP00000292596; ENSG00000213316.
DR   GeneID; 4056; -.
DR   KEGG; hsa:4056; -.
DR   UCSC; uc003mko.4; human.
DR   CTD; 4056; -.
DR   DisGeNET; 4056; -.
DR   GeneCards; LTC4S; -.
DR   HGNC; HGNC:6719; LTC4S.
DR   MalaCards; LTC4S; -.
DR   MIM; 246530; gene.
DR   neXtProt; NX_Q16873; -.
DR   OpenTargets; ENSG00000213316; -.
DR   Orphanet; 79507; Hypotonia - failure to thrive - microcephaly.
DR   PharmGKB; PA235; -.
DR   eggNOG; ENOG410IX5F; Eukaryota.
DR   eggNOG; ENOG4111JV7; LUCA.
DR   GeneTree; ENSGT00430000030964; -.
DR   HOGENOM; HOG000116372; -.
DR   HOVERGEN; HBG105513; -.
DR   InParanoid; Q16873; -.
DR   KO; K00807; -.
DR   OMA; IFRAQAN; -.
DR   OrthoDB; EOG091G12NW; -.
DR   PhylomeDB; Q16873; -.
DR   TreeFam; TF105328; -.
DR   BioCyc; MetaCyc:HS08566-MONOMER; -.
DR   BRENDA; 4.4.1.20; 2681.
DR   Reactome; R-HSA-2142688; Synthesis of 5-eicosatetraenoic acids.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   Reactome; R-HSA-2142700; Synthesis of Lipoxins (LX).
DR   SABIO-RK; Q16873; -.
DR   SignaLink; Q16873; -.
DR   EvolutionaryTrace; Q16873; -.
DR   GeneWiki; Leukotriene_C4_synthase; -.
DR   GenomeRNAi; 4056; -.
DR   PRO; PR:Q16873; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   CleanEx; HS_LTC4S; -.
DR   ExpressionAtlas; Q16873; baseline.
DR   Genevisible; Q16873; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; TAS:ProtInc.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0005640; C:nuclear outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008047; F:enzyme activator activity; IEA:InterPro.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IBA:GO_Central.
DR   GO; GO:0004364; F:glutathione transferase activity; IBA:GO_Central.
DR   GO; GO:0004464; F:leukotriene-C4 synthase activity; IDA:MGI.
DR   GO; GO:0008289; F:lipid binding; IDA:MGI.
DR   GO; GO:0019370; P:leukotriene biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006691; P:leukotriene metabolic process; IDA:MGI.
DR   GO; GO:2001300; P:lipoxin metabolic process; TAS:Reactome.
DR   GO; GO:0019372; P:lipoxygenase pathway; TAS:Reactome.
DR   Gene3D; 1.20.120.550; -; 1.
DR   InterPro; IPR001446; 5_LipOase_AP.
DR   InterPro; IPR018295; FLAP/GST2/LTC4S_CS.
DR   InterPro; IPR023352; MAPEG-like_dom.
DR   InterPro; IPR001129; Membr-assoc_MAPEG.
DR   Pfam; PF01124; MAPEG; 1.
DR   PRINTS; PR00488; 5LPOXGNASEAP.
DR   PROSITE; PS01297; FLAP_GST2_LTC4S; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Endoplasmic reticulum; Leukotriene biosynthesis; Lyase; Membrane;
KW   Nucleus; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    150       Leukotriene C4 synthase.
FT                                /FTId=PRO_0000217748.
FT   TOPO_DOM      1      6       Cytoplasmic.
FT   TRANSMEM      7     27       Helical.
FT   TOPO_DOM     28     48       Lumenal.
FT   TRANSMEM     49     69       Helical.
FT   TOPO_DOM     70     73       Cytoplasmic.
FT   TRANSMEM     74     94       Helical.
FT   TOPO_DOM     95    104       Lumenal.
FT   TRANSMEM    105    124       Helical.
FT   TOPO_DOM    125    150       Cytoplasmic.
FT   REGION       51     55       Glutathione binding.
FT   REGION       58     59       Glutathione binding.
FT   REGION       93     97       Glutathione binding.
FT   ACT_SITE     31     31       Proton donor.
FT                                {ECO:0000305|PubMed:17632548}.
FT   ACT_SITE    104    104       Proton acceptor.
FT                                {ECO:0000305|PubMed:17632548}.
FT   BINDING      30     30       Glutathione.
FT                                {ECO:0000269|PubMed:17632546,
FT                                ECO:0000269|PubMed:17632548}.
FT   VARIANT     142    142       R -> Q (in dbSNP:rs11541078).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_042736.
FT   CONFLICT     21     21       Y -> G (in Ref. 6; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX         2     32       {ECO:0000244|PDB:3PCV}.
FT   HELIX        44     73       {ECO:0000244|PDB:3PCV}.
FT   HELIX        76     99       {ECO:0000244|PDB:3PCV}.
FT   HELIX       101    104       {ECO:0000244|PDB:3PCV}.
FT   HELIX       105    145       {ECO:0000244|PDB:3PCV}.
SQ   SEQUENCE   150 AA;  16567 MW;  04E269B475063037 CRC64;
     MKDEVALLAA VTLLGVLLQA YFSLQVISAR RAFRVSPPLT TGPPEFERVY RAQVNCSEYF
     PLFLATLWVA GIFFHEGAAA LCGLVYLFAR LRYFQGYARS AQLRLAPLYA SARALWLLVA
     LAALGLLAHF LPAALRAALL GRLRTLLPWA
//
